ENZ vs. BDSX, BNR, PSNL, XGN, RNLX, PMD, DMTK, BGLC, FRES, and OPGN
Should you be buying Enzo Biochem stock or one of its competitors? The main competitors of Enzo Biochem include Biodesix (BDSX), Burning Rock Biotech (BNR), Personalis (PSNL), Exagen (XGN), Renalytix (RNLX), Psychemedics (PMD), DermTech (DMTK), BioNexus Gene Lab (BGLC), Fresh2 Group (FRES), and OpGen (OPGN). These companies are all part of the "medical laboratories" industry.
Enzo Biochem (NYSE:ENZ) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership.
Enzo Biochem received 185 more outperform votes than Biodesix when rated by MarketBeat users. However, 72.97% of users gave Biodesix an outperform vote while only 56.53% of users gave Enzo Biochem an outperform vote.
36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 15.5% of Enzo Biochem shares are owned by company insiders. Comparatively, 69.2% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Enzo Biochem has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.
Enzo Biochem has a net margin of 99.28% compared to Biodesix's net margin of -85.80%. Enzo Biochem's return on equity of -36.71% beat Biodesix's return on equity.
In the previous week, Enzo Biochem's average media sentiment score of 0.00 equaled Biodesix'saverage media sentiment score.
Biodesix has a consensus price target of $3.10, suggesting a potential upside of 112.33%. Given Biodesix's higher possible upside, analysts plainly believe Biodesix is more favorable than Enzo Biochem.
Enzo Biochem has higher earnings, but lower revenue than Biodesix.
Summary
Biodesix beats Enzo Biochem on 7 of the 13 factors compared between the two stocks.
Get Enzo Biochem News Delivered to You Automatically
Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ENZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Enzo Biochem Competitors List
Related Companies and Tools
